Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Scott Bornheimer"'
Autor:
Francis Angira, Benta Akoth, Paul Omolo, Valarie Opollo, Scott Bornheimer, Kevin Judge, Henok Tilahun, Beverly Lu, Imelda Omana-Zapata, Clement Zeh
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0157939 (2016)
The BD FACSPresto™ Near-Patient CD4 Counter was developed to expand HIV/AIDS management in resource-limited settings. It measures absolute CD4 counts (AbsCD4), percent CD4 (%CD4), and hemoglobin (Hb) from a single drop of capillary or venous blood
Externí odkaz:
https://doaj.org/article/de1c1abe9a8a4f9da6fdb411df60a7d4
Autor:
Scott Bornheimer, Margaret Nakamoto, Wei Huang, Evelyn Lo, Aaron Middlebrook, Smita Ghanekar, Patrick Neuhoefer, Xiaoshan Shi
Publikováno v:
Cancer Research. 81:2788-2788
Cancer immunotherapies have the potential to induce durable anti-tumor immune responses; however the efficacy of these treatments varies among patients and partially depends on the complex interplay between malignant cells and non-malignant cells wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b852c8b158ba05314c66be35fcaf6f98
https://doi.org/10.1158/1538-7445.am2021-2788
https://doi.org/10.1158/1538-7445.am2021-2788
Autor:
Xiaoshan Shi, Margaret Nakamoto, Aaron Middlebrook, Wei Huang, Evelyn Lo, Patrick Thomas Neuhoefer, Scott Bornheimer, Smita Ghanekar
Publikováno v:
The Journal of Immunology. 206:68.06-68.06
Cancer immunotherapies have the potential to induce durable anti-tumor immune responses; however the efficacy of these treatments varies among patients and partially depends on the complex interplay between malignant cells and non-malignant cells wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc87e2fe160e5ca7ee1a8e2c0eeb287b
https://doi.org/10.4049/jimmunol.206.supp.68.06
https://doi.org/10.4049/jimmunol.206.supp.68.06
Autor:
Xiaoshan Shi, Evelyn Lo, Smita Ghanekar, Patrick Neuhoefer, Wei Huang, Margaret Nakamoto, Aaron Middlebrook, Scott Bornheimer
Publikováno v:
Cancer Research. 80:6197-6197
Single cell multiomic (scM) methods are powerful tools to characterize patient-specific tumor-immune microenvironment, but current methods of sample handling and preparation can introduce bias. Obtaining non-biased results is particularly important i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db7b384106c8c78ed05e64038a39e776
https://doi.org/10.1158/1538-7445.am2020-6197
https://doi.org/10.1158/1538-7445.am2020-6197
Autor:
Mary Hanley, Mamatha Bharadwaj, Chip Lomas, Scott Bornheimer, Suraj Saksena, Elena Afonina, Erika Barboza Prado Lopes
Publikováno v:
The Journal of Immunology. 204:159.51-159.51
The reliance on flow cytometry for phenotypical and functional analyses of immune components in both research and clinical laboratories has increased the need flow cytometric assay standardization. Dried-down reagent cocktails pre-optimized with rega
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f3247258a43f579b6e8ae504920a00f
https://doi.org/10.4049/jimmunol.204.supp.159.51
https://doi.org/10.4049/jimmunol.204.supp.159.51
Autor:
Matthew J. Frigault, Maegan Sheehan, Marcela V. Maus, Alena Chekmasova, Gabrielle Brini, Irene Scarfò, Rebecca C. Larson, Scott Bornheimer, Mark B. Leick, Kathleen Gallagher, Mary Beth Hanley
Publikováno v:
Blood. 134:5626-5626
Chimeric antigen receptor T-cells (CAR-T) have emerged as an extremely promising therapy for hematological malignancies. The immunophenotype of apheresis material and the CAR-T cell product is known to be predictive of the likelihood of response to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04d37150f4f3a155533b4b83d7ae5671
https://doi.org/10.1182/blood-2019-128745
https://doi.org/10.1182/blood-2019-128745
Autor:
Henok Tilahun, Imelda Omana-Zapata, Beverly Lu, Benta Akoth, Paul Omolo, Scott Bornheimer, Francis Angira, Valarie Opollo, Kevin A. Judge, Clement Zeh
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 8, p e0157939 (2016)
PLoS ONE, Vol 11, Iss 8, p e0157939 (2016)
Background The BD FACSPresto™ Near-Patient CD4 Counter was developed to expand HIV/AIDS management in resource-limited settings. It measures absolute CD4 counts (AbsCD4), percent CD4 (%CD4), and hemoglobin (Hb) from a single drop of capillary or ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71afc3aeab210a2c08ffcd6919644470
https://pubmed.ncbi.nlm.nih.gov/27483008
https://pubmed.ncbi.nlm.nih.gov/27483008